Emily Crabtree
Family · Abingdon, VANPI 1639525975
Payments from drug & device makers
Across 216 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$801
- Neurocrine Biosciences, Inc.$737
- Novo Nordisk$737
- AbbVie$719
- Otsuka America Pharmaceutical, Inc.$291
- Lilly USA, LLC$232
- plus $853 from 12 others
What the payments were for
- Food & beverage$4,371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $801 |
| Neurocrine Biosciences, Inc. | 35 | $737 |
| Novo Nordisk | 35 | $737 |
| AbbVie | 54 | $719 |
| Otsuka America Pharmaceutical, Inc. | 13 | $291 |
| Lilly USA, LLC | 14 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $210 |
| Pfizer | 7 | $121 |
| Johnson & Johnson | 7 | $120 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $98 |
| GSK | 3 | $71 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Bayer | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Abbott | 2 | $37 |
| Verona Pharma, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Alkermes, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,371 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 87 | $113,343 |
| MounjaroTirzepatide | 95 | $97,993 |
| EliquisApixaban | 98 | $64,725 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 71 | $57,816 |
| JardianceEmpagliflozin | 57 | $53,035 |
| FarxigaDapagliflozin Propanediol | 30 | $27,589 |
| XareltoRivaroxaban | 33 | $23,433 |
| LinzessLinaclotide | 32 | $19,432 |
| TrulicityDulaglutide | 13 | $18,780 |
| EntrestoSacubitril/Valsartan | 16 | $16,430 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $13,858 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $13,811 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $10,757 |
| BrilintaTicagrelor | 11 | $9,590 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 51 | $7,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $232 | $116,773108 claims |
| Novo NordiskOzempic | $737 | $113,34387 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $71 | $75,030110 claims |
| PfizerEliquis | $121 | $64,72598 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $801 | $51,03762 claims |
| Johnson & JohnsonXarelto | $120 | $23,43333 claims |
| AbbVieLinzess, Synthroid | $719 | $21,33060 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,332 family providers in Virginia.
Other family in Abingdon
- Lora ReynoldsAbingdon$42K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.